Alignment Healthcare, Inc. ALHC
Institutional shares held
147 Million
24.6K
calls
700
puts
Total value of holdings
$1.23B
$205K
calls
$5K
puts
Market Cap
$1.57B
187,250,000
Shares Out.
Institutional ownership
78.3%
# of Institutions
133
We take great care to ensure that the data presented and summarized in this overview for Alignment Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ALHC
View all-
General Atlantic LLC New York, NY61MShares$511 Million7.07% of portfolio
-
Warburg Pincus LLC New York, NY17.9MShares$150 Million5.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$77.3 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.3MShares$69.5 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.27MShares$69.2 Million0.85% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$61.9 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA5.98MShares$50.1 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.87MShares$40.7 Million0.01% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$24.4 Million0.37% of portfolio
-
State Street Corp Boston, MA2.11MShares$17.6 Million0.0% of portfolio
Latest Institutional Activity in ALHC
Top Purchases
Top Sells
About ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Insider Transactions at ALHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.29%
|
$9,600
$8.06 P/Share
|
|
Jun 14
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
16,000
-3.65%
|
$128,000
$8.01 P/Share
|
|
Jun 12
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.01%
|
$160,000
$8.21 P/Share
|
|
Mar 28
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,363
-1.0%
|
$17,452
$4.84 P/Share
|
|
Mar 28
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,299
-0.49%
|
$17,196
$4.84 P/Share
|
|
Mar 28
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
10,151
-0.51%
|
$40,604
$4.84 P/Share
|
|
Mar 28
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
1,821
-0.42%
|
$7,284
$4.84 P/Share
|
|
Mar 20
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
13,252
-0.66%
|
$53,008
$4.83 P/Share
|
|
Mar 19
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,522
-3.18%
|
$142,610
$5.05 P/Share
|
|
Mar 19
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
18,964
-4.18%
|
$94,820
$5.05 P/Share
|
|
Mar 19
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,576
-0.99%
|
$27,880
$5.05 P/Share
|
|
Mar 19
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
25,060
-5.4%
|
$125,300
$5.05 P/Share
|
|
Mar 19
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,078
-0.7%
|
$15,390
$5.05 P/Share
|
|
Mar 19
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
15,861
-0.79%
|
$79,305
$5.05 P/Share
|
|
Mar 15
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,326
-0.94%
|
$17,304
$4.89 P/Share
|
|
Mar 15
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,858
-1.3%
|
$47,432
$4.89 P/Share
|
|
Mar 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
21,537
-1.06%
|
$86,148
$4.89 P/Share
|
|
Mar 15
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,852
-1.09%
|
$19,408
$4.89 P/Share
|
|
Mar 14
2024
|
John E Kao Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
103,000
+3.62%
|
$412,000
$4.82 P/Share
|
|
Mar 13
2024
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+0.16%
|
-
|
Last 12 Months Summary
Buy / Acquisition
3.44M
Shares
From
23
Insiders
| Grant, award, or other acquisition | 3.34M shares |
|---|---|
| Open market or private purchase | 103K shares |
Sell / Disposition
303K
Shares
From
10
Insiders
| Open market or private sale | 262K shares |
|---|---|
| Payment of exercise price or tax liability | 34.5K shares |
| Bona fide gift | 6K shares |